The 7 analysts offering 12-month price forecasts for Ocular Therapeutix Inc have a median target of 16.00, with a high estimate of 29.00 and a low estimate of 10.00. The median estimate represents a +401.57% increase from the last price of 3.19.
The current consensus among 7 polled investment analysts is to Buy stock in Ocular Therapeutix Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.24
Reporting Date Aug 09
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.